会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • OXYGEN ENHANCING MEMBRANE SYSTEMS FOR IMPLANTABLE DEVICES
    • 用于可植入设备的氧气增强膜系统
    • WO2005011520A3
    • 2005-12-15
    • PCT/US2004023454
    • 2004-07-21
    • DEXCOM INCPETISCE JAMES RTAPSAK MARK ASIMPSON PETER CCARR-BRENDEL VICTORIA
    • PETISCE JAMES RTAPSAK MARK ASIMPSON PETER CCARR-BRENDEL VICTORIA
    • A61B5/00A61B5/05A61F20060101G01N27/327
    • A61B5/1473A61B5/145A61B5/14503A61B5/14532A61B5/14546A61B5/1468A61B5/14735A61B5/14865
    • The present invention relates generally to systems and methods for increasing oxygen availability to implantable devices. The preferred embodiments provide a membrane system (18) configured to provide protection of the device from the biological environment and/or a catalyst for enabling an enzymatic reaction, wherein the membrane system includes a polymer formed from a high oxygen soluble material. The high oxygen soluble polymer material is disposed adjacent to an oxygen-utilizing source on the implantable device so as to dynamically retain high oxygen availability to the oxygen-utilizing source during oxygen deficits. The membrane system (18) can include a cell disruptive domain (40), a cell impermeable domain (42), a resistance domain (44), an enzyme domain (46), an interference domain (48), and an electrolyte domain (50) adjacent to the electrochemically reactive surfaces. Membrane systems of the preferred embodiments are useful for implantable devices with oxygen-utilizing sources and/or that function in low oxygen environments, such as enzyme-based electrochemical sensors and cell transplantation devices.
    • 本发明一般涉及用于增加可植入装置的氧气可用性的系统和方法。 优选的实施方案提供了一种膜系统(18),其被配置为提供该装置与生物环境的保护和/或用于实现酶反应的催化剂,其中所述膜系统包括由高氧可溶性材料形成的聚合物。 高氧可溶性聚合物材料与可植入装置上的氧气源相邻设置,以便在缺氧期间动态地保持氧利用源的高氧可利用性。 膜系统(18)可以包括细胞破碎结构域(40),细胞不可渗透结构域(42),电阻结构域(44),酶结构域(46),干扰结构域(48)和电解质结构域 邻近电化学反应的表面。 优选实施方案的膜系统对于具有氧利用源的可植入装置和/或在低氧环境中起作用,例如基于酶的电化学传感器和细胞移植装置是有用的。
    • 7. 发明申请
    • BIOINTERFACE WITH MACRO- AND MICRO- ARCHITECTURE
    • 具有宏观和微观结构的生物界
    • WO2005079257A2
    • 2005-09-01
    • PCT/US2005004058
    • 2005-02-09
    • DEXCOM INCCARR-BRENDEL VICTORIASIMPSON PETER CBRAUKER JAMES H
    • CARR-BRENDEL VICTORIASIMPSON PETER CBRAUKER JAMES H
    • A61F13/00A61L31/10A61L31/14A61L31/16
    • A61L31/10A61L31/146A61L31/16A61L2300/10B33Y80/00
    • Disclosed herein are biointerface membranes including a macro-architecture and a micro-architecture co-continuous with and bonded to and/or located within at least a portion of the macro-architecture.The macro- and micro-architectures work together to manage and manipulate the high-level tissue organization and the low-level cellular organization of the foreign body response in vivo, thereby increasing neovascularization close to a device-tissue interface, interfering with barrier cell layer formation, and providing good tissue anchoring, while reducing the effects of motion artifact, and disrupting the organization and/or contracture of the foreign body capsule. The biointerface membranes of the preferred embodiments can be utilized with implantable devices such as devices for the detection of analyte concentrations in a biological sample (for example, from a body), cell transplantation devices, drug delivery devices, electrical signal delivering or measuring devices, and/or combinations thereof.
    • 这里公开的是生物界面膜,其包括宏观架构和与宏结构共同连接并结合到宏结构和/或位于宏观架构的至少一部分内的微架构。宏观和微观架构一起工作以管理和操纵 高水平组织组织和体内异物反应的低水平细胞组织,从而增加靠近器官组织界面的新生血管形成,干扰屏障细胞层形成,并提供良好的组织锚定,同时降低 运动神器,并扰乱异物胶囊的组织和/或挛缩。 优选实施方案的生物界面膜可以与可植入装置一起使用,例如用于检测生物样品(例如,来自身体),细胞移植装置,药物递送装置,电信号传递或测量装置中的分析物浓度的装置, 和/或其组合。